Liberty Biopharma (CVE:LTY) Stock Price Crosses Above Fifty Day Moving Average of $2.00

Shares of Liberty Biopharma Inc (CVE:LTY) crossed above its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of C$2.00 and traded as high as C$2.00. Liberty Biopharma shares last traded at C$2.00, with a volume of 700 shares traded.

Liberty Biopharma Stock Up ∞

The business has a 50-day moving average price of C$2.00 and a 200-day moving average price of C$2.00. The stock has a market cap of C$21.54 million and a PE ratio of -12.66. The company has a current ratio of 0.12, a quick ratio of 0.12 and a debt-to-equity ratio of 8.19.

Liberty Biopharma Company Profile

Liberty Biopharma Inc, a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of an automated bioprocessing and cell isolation technology. Its technology is used in the isolation of regenerative cells from human adipose tissues for use in research, cosmetic and aesthetic medicine, burn management, wound management and non-healing wounds, cardiovascular and heart diseases, peripheral arterial disease, critical limb ischemia or diabetic leg, and hepatic disease and kidney disease.